Navigation Links
Stem Cell Sciences Signs Service Agreement With Pfizer to Provide Access to Proprietary Technologies and Methods
Date:11/20/2008

CAMBRIDGE, England, November 20 /PRNewswire-FirstCall/ -- Stem Cell Sciences plc (AIM:STEM, ASX:STC), a company focused on the commercialisation of stem cells and stem cell technologies, has signed a Master Service Agreement of up to five years with Pfizer Limited, the UK operating unit of the global research-based pharmaceutical company Pfizer, Inc. (NYSE: PFE). Under the terms of the agreement, SCS will provide research services, cell lines, media and reagents to support Pfizer's R&D efforts in this important field.

Dr Alastair Riddell, CEO of SCS, said, "The opening of Pfizer's new regenerative medicine research facility in Cambridge, UK, last week is very important for stem cell research and reinforces the UK's position as an international centre of excellence. We are therefore very pleased to be able to support Pfizer's efforts to advance biomedical research under our new agreement."

The Pfizer regenerative medicine unit will be led by Chief Scientific Officer, Ruth McKernan, PhD, who said, "I'm very excited to lead this new research unit. While there is still a lot to understand about how stem cells can be used therapeutically, we believe it is one of the most promising areas of scientific research. Building successful partnerships with companies such as Stem Cell Sciences will be important for us."

About Stem Cell Sciences plc

Stem Cell Sciences (SCS) is an international research and development company focusing on the commercial application of stem cell biology technologies for drug discovery and regenerative medicine research. Stem Cell Sciences is now focussing on building revenues through the sale of products, collaborative research and licensing deals with international biotechnology and pharmaceutical companies.

Stem Cell Sciences has a substantial portfolio of p
'/>"/>

SOURCE Stem Cell Sciences plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
2. BBM Announces Offer to Acquire YM BioSciences Inc.
3. Human Pheromone Sciences Announces Third Quarter Results
4. Stem Cell Sciences Licenses Stem Cell Technology to Leading Provider of Genetically Modified Models for Pharmaceutical Research
5. Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
6. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
7. Stem Cell Sciences Enters into Services Agreement with Huntingdons Disease Research Group, CHDI Foundation Inc.
8. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Deutsche Bank Conference
9. Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
10. Advanced Life Sciences Announces Third Quarter 2008 Financial Results
11. LI-COR Biosciences and Mandel Scientific Company Inc. Announce Distribution Agreement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... , DALLAS, Dec. 3 /PRNewswire-FirstCall/...in Board: ACCP), today provided an update on its E...ed treatment for oral mucositis, a debilitating si... MuGard is commercially launched by Access, partne...the UK, Germany, Italy, Norway, Greece and Sweden....
(Date:12/3/2009)... , TUSTIN, Calif., Dec. 3 /PRNewswire-Firs... PPHM ) today announced that it will release its ... year 2010 on December 10, 2009 at 7:00 a.m. EST a...uss the results at 11:30 a.m. EST on the same day....financial results for the second quarter ended Oct...
(Date:12/3/2009)... , NEW DELHI, India, Dec. 3 /PRNew... Science Officer at Shenzhen Beike Biotechnology C... a conference on High-Risk Diabetic,Foot Care in N...,s leading,stem cell research and regenerative med...d by the Indian Podiatry Association (IPA), aimed,...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Repo...report is available in its catalogue: ,, Neuro...http://www.reportlinker.com/p0164232/Neurostimulat... world neurostimulation market stands enthused by ...ltant rise in age-related diseases such as, Parkin...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6
...Genaera,Corporation (Nasdaq: GENR ) today announc...ch 31, 2008. The net loss for the quarter ended Ma... and diluted share, as compared,to a net loss of $...e, for,the quarter ended March 31, 2007., Genaera...er ended March,31, 2008 were $3.8 million compared...
...st - Toronto Stock Exchange Symb...BioMS Medical Corp (TSX: MS),a leading developer i...announced an update on its pipeline products, HYC7...y has entered into a Royalty and Assignment Agreem...y based on hyaluronic acid that,has a number of po...
...lexander von Humboldt,Foundation, one of the world...ed that it has named Dr. Robert Knight as a winner... for 2008 in the area of neurobiology.,It is the o...gory., Headquartered in Bonn, Germany, the Humbol...nal candidates each year for its awards program.,N...
Other Biology Technology:Genaera Corporation Announces First Quarter Financial Results 2Genaera Corporation Announces First Quarter Financial Results 3Genaera Corporation Announces First Quarter Financial Results 4BioMS Medical Provides Update On Pipeline Products 2BioMS Medical Provides Update On Pipeline Products 3NeuroFocus Chief Science Advisor Wins Humboldt Prize 2
(Date:12/3/2009)... change in warmer water, according to an intriguin...e some species more aggressive. , Experiments wi...Great Barrier Reef have shown for the first time t...or consistently bold, and that these individual di...es rise. , A slight lift of just one or two degr...
(Date:12/3/2009)...esign of the upcoming forest deal at Copenhagen in...o a scientist at the University of Leeds. , Wri... at least 50% of the carbon credit payments to be ...sions from Deforestation and Degredation), should ...perty rights assured. , "There is the potential ...
(Date:12/3/2009)...nvestment in energy efficient technologies researc...Council (EPSRC) Chief Executive Dave Delpy believe... research has already brought us fuel cells, marin...ment is needed to develop the capabilities of diff...ion targets by 2020 and limit the impact of climat...
Breaking Biology News(10 mins):Fish with attitude: Some like it hot 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Research is vital to a cleaner, greener, low carbon future 2MRI accurately depicts deep endometriosis 50842 1MRI accurately depicts deep endometriosis 50842 2News briefs from the July issue of CHEST 50840 1News briefs from the July issue of CHEST 50840 2Expert Explains Why Propofol Was the Wrong and Possibly Fatal Drug for Michael Jackson 50839 1Expert Explains Why Propofol Was the Wrong and Possibly Fatal Drug for Michael Jackson 50839 2
...ough the lens of the microscope at tiny sections o...nnual bands of growth. She carefully counts the ba...n to the next sample. Known as an age reader, Sut...Fisheries Science Center (NEFSC) whose aging work ...the nations fishery resources in the Northwest Atl...
.... , , Bonn/Berlin. What will the loss of biodiver...l economies need to invest now in order to stop th...do not act" These are the questions the TEEB -- Th...ct is seeking to answer. The pilot study led by Pa... Market Centre in London, was commissioned by the ...
...s that control electrical excitability in a portio...ke insomnia disorder in mice, UT Southwestern Medi...y help scientists better understand the disorder a...ts. , This is one of the most dramatic sleep-dis...professor of neuroscience and senior author of the...
Other Biology News:Saltwater sleuths: Seeking clues to help determine the ages of fish and shellfish populations 2Saltwater sleuths: Seeking clues to help determine the ages of fish and shellfish populations 3Saltwater sleuths: Seeking clues to help determine the ages of fish and shellfish populations 4Biodiversity as a natural resource 2Gene mutations in mice mimic human-like sleep disorder, UT Southwestern researchers find 2
RNA Sample Buffer from Novagen
Eppendorf capping aid from Sigma-Aldrich
...d, the Quansys Biosciences Q-Plex Array is a new t...okines for human, mouse, and rat research. The Q-P...SA-based test where 4 distinct capture antibodies ... in a defined array. Analytes measured are IL-2, ...
Strip Cap Tool from Bio-Rad
Biology Products: